Efficacy and Safety of Pregabalin versus Duloxetine in Lumbar Radiculopathy after Decompression Surgery: A Systematic review and Meta-analysis
International Journal of Drug Delivery Technology · 19.06.2026 · 16 (56s)
DOI: 10.25258/ijddt.16.56s.87 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 19.06.2026. Verfasst von Tanu Kumari und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background- Lumbar radiculopathy is a common cause of neuropathic lower back and leg pain that frequently persists even after lumbar decompression surgery. Persistent postoperative neuropathic pain negatively affects rehabilitation, mobility, and overall quality of life. Pregabalin and duloxetine are widely used pharmacological agents for postoperative neuropathic pain management; however, comparative evidence regarding their efficacy and safety remains limited and inconsistent. Objective- To compare the efficacy and safety of pregabalin versus duloxetine in patients with lumbar radiculopathy after decompression surgery through a systematic review and meta-analysis. Materials and Methods- A systematic literature search was conducted using PubMed, Scopus, Embase, Web of Science, and Cochrane CENTRAL databases for studies published up to January 2026. Randomized controlled trials and comparative observational studies evaluating pregabalin and duloxetine in postoperative lumbar radiculopathy patients were included. Primary outcomes included postoperative pain scores and functional disability outcomes. Secondary outcomes included rescue analgesic consumption and adverse events. Pooled mean differences (MD) and odds ratios (OR) with 95% confidence intervals (CI) were calculated using fixed- or random-effects models depending on heterogeneity. Results- Eight studies involving 742 patients were included in the meta-analysis. Duloxetine demonstrated significantly greater reduction in postoperative pain scores compared with pregabalin (MD = −0.64; 95% CI: −1.02 to −0.26; p = 0.001). Functional recovery assessed using the Oswestry Disability Index also favored duloxetine (MD = −3.21; 95% CI: −5.47 to −0.95; p = 0.005). Rescue analgesic consumption was lower in the duloxetine group, although statistical significance was not achieved (OR = 0.79; 95% CI: 0.58–1.06; p = 0.11). Pregabalin was associated with significantly higher incidences of dizziness (OR = 1.74; 95% CI: 1.12–2.68; p = 0.01) and somnolence (OR = 1.89; 95% CI: 1.21–2.94; p = 0.004), whereas duloxetine showed slightly higher rates of nausea and dry mouth. Overall treatment discontinuation rates were comparable between both groups. Conclusion- Both pregabalin and duloxetine are effective options for postoperative neuropathic pain management after lumbar decompression surgery. Duloxetine appears to provide superior medium-term pain reduction and improved functional recovery with fewer neurologic adverse effects compared with pregabalin. Further large-scale multicenter randomized controlled trials are required to establish definitive postoperative neuropathic pain management guidelines
Zitieren
APA
Kumari, T., Singh, D. K., & Srivastava, S. (2026). Efficacy and Safety of Pregabalin versus Duloxetine in Lumbar Radiculopathy after Decompression Surgery: A Systematic review and Meta-analysis. International Journal of Drug Delivery Technology, 16(56s). https://doi.org/10.25258/ijddt.16.56s.87
Vancouver
Kumari T, Singh DK, Srivastava S. Efficacy and Safety of Pregabalin versus Duloxetine in Lumbar Radiculopathy after Decompression Surgery: A Systematic review and Meta-analysis. International Journal of Drug Delivery Technology. 2026;16(56s). doi:10.25258/ijddt.16.56s.87
BibTeX
@article{Kumari2026,
author = {Kumari, Tanu and Singh, Deepak Kumar and Srivastava, Shubham},
title = {Efficacy and Safety of Pregabalin versus Duloxetine in Lumbar Radiculopathy after Decompression Surgery: A Systematic review and Meta-analysis},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {56s},
doi = {10.25258/ijddt.16.56s.87}
}
EUVIMED